Nine Directors at Kindred Healthcare Inc sold 886,006 shares at 9.000USD. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
LOUISVILLE, Ky.--(BUSINESS WIRE)-- Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced that at its special meeting of stockholders, stockholders approved the transaction with affiliates of TPG Capital, Welsh, Carson, Anderson & Stowe and Humana Inc. (NYSE:HUM) (together, the “consortium”). The final vote results will be reported on a Form 8-K filed with the Securities and Exchange Commission. Benjamin A. Breier, President and Chief Executive Officer of Kindred, said, “We are pleased that the trans...
NEW YORK--(BUSINESS WIRE)-- Brigade Capital Management, LP (“Brigade”), on behalf of funds managed by it, today responded to yesterday’s press release by Kindred Healthcare, Inc. (NYSE: KND) (“Kindred” or the “Company”) to correct what Brigade views as misleading statements by Kindred. Brigade believes Kindred’s shareholders deserve better and should vote “NO” to the proposed acquisition of the Company by a consortium of Humana, TPG Capital and Welsh, Carson, Anderson & Stowe. Kindred’s March 27, 2018 press release states tha...
LOUISVILLE, Ky.--(BUSINESS WIRE)-- Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced that leading proxy advisory firm Egan-Jones Rating Company (“Egan-Jones”) joined Institutional Shareholder Services (“ISS”) in recommending that Kindred stockholders vote “FOR” the transaction with affiliates of TPG Capital, Welsh, Carson, Anderson & Stowe and Humana Inc. (NYSE: HUM) (together, the “consortium”). The Kindred Board of Directors is confident that the transaction is in the best interest of all Kind...
NEW YORK--(BUSINESS WIRE)-- Brigade Capital Management, LP (“Brigade”), on behalf of funds managed by it, announced today that it strongly supports the recommendation by leading independent institutional investor advisor, Glass Lewis, to vote AGAINST the Kindred Healthcare’s 2018 merger-related proxy proposals. In its report, Glass Lewis highlights its concerns regarding the questionable timing and unattractive financial terms of the transaction, as well as the excessive senior executive compensation that would become payable upon sha...
NEW YORK--(BUSINESS WIRE)-- Brigade Capital Management, LP (“Brigade”), on behalf of funds managed by it, today released its letter to the CEO and Board of Directors (the “Board”) of Kindred Healthcare, Inc. (NYSE:KND) (“Kindred” or the “Company”) definitively stating its intention to vote “NO” to the proposed acquisition of the Company by a consortium of Humana, TPG Capital and Welsh, Carson, Anderson & Stowe. In its letter, Brigade cited the following reasons for its opposition: the ill-timed sale short-changes sto...
LOUISVILLE, Ky.--(BUSINESS WIRE)-- Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced that leading independent proxy advisory firm Institutional Shareholder Services Inc. (“ISS”) recommends that Kindred stockholders vote “FOR” the transaction with affiliates of TPG Capital, Welsh, Carson, Anderson & Stowe and Humana Inc. (NYSE: HUM) (together, the “consortium”). Commenting on the report, Benjamin A. Breier, President and Chief Executive Officer of Kindred, said, “We are pleased that ISS recognize...
LOUISVILLE, Ky.--(BUSINESS WIRE)-- Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced its operating results for the fourth quarter and full year ended December 31, 2017. The Company also today will file its Annual Report on Form 10-K with the Securities and Exchange Commission (“SEC”). On December 19, 2017, the Company announced that its Board of Directors approved a definitive agreement under which it will be acquired by a consortium of three companies: TPG Capital (“TPG”), Welsh, Carson, Anders...
WILMINGTON, Del.--(BUSINESS WIRE)-- Rigrodsky & Long, P.A.: Do you own shares of Kindred Healthcare, Inc. (NYSE: KND)? Did you purchase any of your shares prior to December 19, 2017? Do you think the proposed buyout is fair? Do you want to discuss your rights? Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE: KND) regar...
STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Kindred Healthcare, Inc. (NYSE: KND) (“Kindred Healthcare” or the “Company”) relating to the proposed buyout of Kindred Healthcare by a consortium of three companies: TPG Capital, Welsh, Carson, Anderson & Stowe and Humana Inc. Under the terms of the agreement, Kindred Healthcare s...
NEW YORK--(BUSINESS WIRE)-- Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of Kindred Healthcare, Inc. (NYSE:KND) stockholders concerning the proposed acquisition of the company by TPG Capital, Welsh, Carson, Anderson & Stowe, and Humana Inc. (NYSE:HUM) (collectively, the “consortium”). Our investigation concerns whether Kindred’s board of directors failed to adequately shop the company and obtain the best possible value for its stockholders before entering into a definitive merger agreement with ...
WILMINGTON, Del.--(BUSINESS WIRE)-- Rigrodsky & Long, P.A.: Do you own shares of Kindred Healthcare, Inc. (NYSE: KND)? Did you purchase any of your shares prior to December 19, 2017? Do you think the proposed buyout is fair? Do you want to discuss your rights? Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE: KND) regar...
NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Kindred Healthcare, Inc. (“Kindred Healthcare” or the “Company”) (NYSE: KND) stock prior to December 19, 2017. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Kindred Healthcare to a consortium composed of TPG Capital, Welsh, Carson, Anderson & Stowe, and Humana Inc. for $9 per share. To learn more about the ac...
LOUISVILLE, Ky.--(BUSINESS WIRE)-- Kindred Healthcare, Inc. (“Kindred” or “the Company”) (NYSE:KND) today announced that its Board of Directors has approved a definitive agreement under which it will be acquired by a consortium of three companies: TPG Capital (“TPG”), Welsh, Carson, Anderson & Stowe (“WCAS”) and Humana Inc. (“Humana”) (NYSE: HUM) (together, the “consortium”) for approximately $4.1 billion in cash including the assumption or repayment of net debt. Under the terms of the agreement, Kindred stockholders will rec...
LOUISVILLE, Ky.--(BUSINESS WIRE)-- Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced that it has completed additional transaction closings (the “Closings”) related to its previously announced agreement with BM Eagle Holdings, LLC, a joint venture led by affiliates of BlueMountain Capital Management, LLC (“BlueMountain”), to sell the Company’s skilled nursing facility business. Since October 1, 2017, the Closings included 12 skilled nursing facilities and one assisted living facility. Sale procee...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.